Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus net income
Net income is the profit left for shareholders after every expense, interest and tax.
Nu-Med Plus's net income for the twelve months ending Jun 30, 2026 was -$20.79K. For fiscal 2025 it was -$56.18K. The highest annual figure on record is $9.65M in fiscal 2016.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$56.18K | – |
| FY2024 | Dec 31, 2024 | -$68.35K | – |
| FY2023 | Dec 31, 2023 | -$125.53K | – |
| FY2022 | Dec 31, 2022 | -$130.17K | – |
| FY2021 | Dec 31, 2021 | -$830.06K | – |
| FY2020 | Dec 31, 2020 | -$2.01M | – |
| FY2019 | Dec 31, 2019 | -$1.04M | – |
| FY2018 | Dec 31, 2018 | -$1.19M | -133.2% |
| FY2017 | Dec 31, 2017 | $3.58M | -62.9% |
| FY2016 | Dec 31, 2016 | $9.65M | – |
| FY2015 | Dec 31, 2015 | -$8.88M | – |
| FY2014 | Dec 31, 2014 | -$1.19M | – |
| FY2013 | Dec 31, 2013 | -$332.29K | – |
| FY2012 | Dec 31, 2012 | -$262.74K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $19.67K | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.88K | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.62K | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.97K | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.67K | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.93K | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.56K | – |
| Q3 FY2024 | Sep 30, 2024 | -$18.68K | – |
| Q2 FY2024 | Jun 30, 2024 | -$17.29K | – |
| Q1 FY2024 | Mar 31, 2024 | -$21.83K | – |
| Q4 FY2023 | Dec 31, 2023 | -$56.60K | -232.8% |
| Q3 FY2023 | Sep 30, 2023 | -$16.41K | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.32K | – |
| Q1 FY2023 | Mar 31, 2023 | -$28.20K | – |
| Q4 FY2022 | Dec 31, 2022 | $42.61K | – |
| Q3 FY2022 | Sep 30, 2022 | -$58.05K | – |
| Q2 FY2022 | Jun 30, 2022 | -$58.07K | – |
| Q1 FY2022 | Mar 31, 2022 | -$56.65K | – |
| Q4 FY2021 | Dec 31, 2021 | -$112.34K | – |
| Q3 FY2021 | Sep 30, 2021 | -$118.37K | – |
| Q2 FY2021 | Jun 30, 2021 | -$242.61K | – |
| Q1 FY2021 | Mar 31, 2021 | -$356.75K | – |
| Q4 FY2020 | Dec 31, 2020 | -$493.37K | – |
| Q3 FY2020 | Sep 30, 2020 | -$453.82K | – |
| Q2 FY2020 | Jun 30, 2020 | -$908.47K | – |
| Q1 FY2020 | Mar 31, 2020 | -$153.33K | – |
| Q4 FY2019 | Dec 31, 2019 | -$209.87K | – |
| Q3 FY2019 | Sep 30, 2019 | -$150.58K | – |
| Q2 FY2019 | Jun 30, 2019 | -$248.18K | – |
| Q1 FY2019 | Mar 31, 2019 | -$428.20K | – |
| Q4 FY2018 | Dec 31, 2018 | -$340.96K | – |
| Q3 FY2018 | Sep 30, 2018 | -$526.85K | -113.2% |
| Q2 FY2018 | Jun 30, 2018 | -$173.56K | – |
| Q1 FY2018 | Mar 31, 2018 | -$147.49K | – |
| Q2 FY2017 | Jun 30, 2017 | -$116.05K | – |
| Q1 FY2017 | Mar 31, 2017 | $3.99M | – |
See a number that looks wrong?